news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
humsci.stanford.edu/feature/new-...
humsci.stanford.edu/feature/new-...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
www.nytimes.com/2025/04/28/o...
www.nytimes.com/2025/04/28/o...
Bispecific antibodies targeting the N-terminal and receptor binding domains potently neutralize SARS-CoV-2 variants of concern | Science Translational Medicine www.science.org/doi/10.1126/...
Bispecific antibodies targeting the N-terminal and receptor binding domains potently neutralize SARS-CoV-2 variants of concern | Science Translational Medicine www.science.org/doi/10.1126/...
humsci.stanford.edu/feature/new-...
humsci.stanford.edu/feature/new-...
news.wsu.edu/press-releas...
news.wsu.edu/press-releas...
news.wsu.edu/press-releas...
news.wsu.edu/press-releas...